Case number 2018-1612
Washington Research Foundation v. Sanofi > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 15, 2019 | 45 | ORDER filed granting motion to dismiss appeal pursuant to FRAP 42(b) [44] filed by Appellants Genentech, Inc. and Washington Research Foundation; issuing mandate. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [586508] [PBC] [Entered: 02/15/2019 03:30 PM] (2) |
| Feb 15, 2019 | 44 | MOTION of Appellants Genentech, Inc. and Washington Research Foundation to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 02/15/2019 by email. [586261] [18-1612] [David Gindler] [Entered: 02/15/2019 10:15 AM] (6) |
| Feb 14, 2019 | 43 | MOTION of Appellants Genentech, Inc. and Washington Research Foundation to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 02/14/2019 by email. [586186] [18-1612] [David Gindler] [Entered: 02/14/2019 06:41 PM] (2) |
| Jan 22, 2019 | 42 | NOTICE OF ORAL ARGUMENT. Panel: 1903G. Case scheduled Mar 05, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to Notice of Oral Argument due: 02/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [579736] [JAB] [Entered: 01/22/2019 01:52 PM] (2) |
| Sep 21, 2018 | 41 | Notice from Appellees Sanofi and Sanofi-Aventis U.S., LLC regarding conflicts with oral argument (No conflicts for the next three court weeks, or January 2019). Service: 09/21/2018 by email. [551852] [18-1612] [Lisa Ferri] [Entered: 09/21/2018 04:30 PM] (2) |
| Sep 20, 2018 | 40 | Notice from Appellants Genentech, Inc. and Washington Research Foundation regarding conflicts with oral argument (Counsel is unavailable on October 1-5, 2018; November 5-9 2018; January 7-11, 2019.). Service: 09/20/2018 by email. [551348] [18-1612] [David Gindler] [Entered: 09/20/2018 12:25 PM] (2) |
| Sep 20, 2018 | 39 | 6 paper copies of the Confidential Joint Appendix Brief [34] received from Appellants Genentech, Inc. and Washington Research Foundation. [551347] [CJF] [Entered: 09/20/2018 12:24 PM] (0) |
| Sep 19, 2018 | 38 | 6 paper copies of the Confidential Opening Response Brief [31] received from Appellees Sanofi and Sanofi-Aventis U.S., LLC. [551032] [CJF] [Entered: 09/19/2018 01:35 PM] (0) |
| Sep 18, 2018 | 37 | 6 paper copies of the Reply Brief [33] received from Appellants Genentech, Inc. and Washington Research Foundation. [550716] [CJF] [Entered: 09/18/2018 01:18 PM] (0) |
| Sep 14, 2018 | 36 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 09/21/2018. [549711] [JB] [Entered: 09/14/2018 09:35 AM] (0) |
| Sep 14, 2018 | 35 | APPENDIX FILED for Genentech, Inc. and Washington Research Foundation [28]. Number of Pages: 353. Service: 08/27/2018 by email. Paper copies should be provided of the confidential version only. [549710] [JB] [Entered: 09/14/2018 09:34 AM] (353) |
| Sep 14, 2018 | 34 | CONFIDENTIAL JOINT APPENDIX FILED for Genentech, Inc. and Washington Research Foundation [27]. Number of Pages: 366. Service: 08/27/2018 by email, US mail. The paper copies of the brief should be received by the court on or before 09/21/2018. [549693] [JB] [Entered: 09/14/2018 09:11 AM] (0) |
| Sep 14, 2018 | 33 | REPLY BRIEF FILED for Appellants Genentech, Inc. and Washington Research Foundation [23]. Number of Pages: 21. Service: 08/20/2018 by email. The paper copies of the brief should be received by the court on or before 09/21/2018. [549688] [JB] [Entered: 09/14/2018 09:03 AM] (28) |
| Sep 14, 2018 | 32 | BRIEF FILED for Appellees Sanofi and Sanofi-Aventis U.S., LLC [22]. Number of Pages: 52. Service: 08/06/2018 by email. Paper copies should be provided of the confidential version only. [549686] [JB] [Entered: 09/14/2018 08:58 AM] (62) |
| Sep 14, 2018 | 31 | CONFIDENTIAL BRIEF FILED for Appellees Sanofi and Sanofi-Aventis U.S., LLC [21]. Number of Pages: 52. Service: 08/06/2018 by email. The paper copies of the brief should be received by the court on or before 09/21/2018. [549685] [JB] [Entered: 09/14/2018 08:53 AM] (0) |
| Sep 14, 2018 | 30 | ORDER filed. The motion [20] is granted. The confidential and non-confidential versions of Sanofi's response brief are accepted for filing. Service: 09/14/2018 by clerk. [549660] [LMS] [Entered: 09/14/2018 07:10 AM] (2) |
| Aug 31, 2018 | 29 | The brief submitted by Appellants Genentech, Inc. and Washington Research Foundation [28], [27] cannot be filed at this time; reason: Appellee's response brief has not yet been accepted. [546656] [JB] [Entered: 08/31/2018 11:16 AM] (0) |
| Aug 27, 2018 | 28 | TENDERED from Appellants Genentech, Inc. and Washington Research Foundation. Title: JOINT APPENDIX. Service: 08/27/2018 by email. [545726] [18-1612] [David Gindler] [Entered: 08/27/2018 06:50 PM] (353) |
| Aug 27, 2018 | 27 | TENDERED from Appellants Genentech, Inc. and Washington Research Foundation. Title: CONFIDENTIAL JOINT APPENDIX Service: 08/27/2018 by email, US mail. [545725] [18-1612] [David Gindler] [Entered: 08/27/2018 06:42 PM] (0) |
| Aug 27, 2018 | 26 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Genentech, Inc. and Washington Research Foundation. Service: 08/27/2018 by email. [545697] [18-1612] [David Gindler] [Entered: 08/27/2018 04:47 PM] (3) |
| Aug 27, 2018 | 25 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Genentech, Inc., Washington Research Foundation and Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 08/27/2018 by email. [545695] [18-1612] [David Gindler] [Entered: 08/27/2018 04:44 PM] (3) |
| Aug 27, 2018 | 24 | The brief submitted by Appellants Genentech, Inc. and Washington Research Foundation [23] cannot be filed at this time; reason: Appellee's response brief has not yet been accepted. [545591] [JB] [Entered: 08/27/2018 01:59 PM] (0) |
| Aug 20, 2018 | 23 | TENDERED from Appellants Genentech, Inc. and Washington Research Foundation. Title: REPLY BRIEF. Service: 08/20/2018 by email. [544199] [18-1612] [David Gindler] [Entered: 08/20/2018 09:54 PM] (28) |
| Aug 6, 2018 | 22 | TENDERED from Appellees Sanofi and Sanofi-Aventis U.S., LLC. Title: RESPONSE BRIEF. Service: 08/06/2018 by email. [541079] [18-1612] [Lisa Ferri] [Entered: 08/06/2018 04:54 PM] (62) |
| Aug 6, 2018 | 21 | TENDERED from Appellees Sanofi and Sanofi-Aventis U.S., LLC. Title: CONFIDENTIAL RESPONSE BRIEF Service: 08/06/2018 by email. [541078] [18-1612] [Lisa Ferri] [Entered: 08/06/2018 04:53 PM] (0) |
| Aug 6, 2018 | 20 | MOTION of Appellees Sanofi and Sanofi-Aventis U.S., LLC to waive confidentiality requirements [Consent: unopposed]. Service: 08/06/2018 by email. [541077] [18-1612] --[Edited 08/09/2018 by CAB to revise docket text to reflect proper relief] [Lisa Ferri] [Entered: 08/06/2018 04:51 PM] (20) |
| Jun 29, 2018 | 19 | 6 paper copies of the Opening Brief [18] received from Appellants Genentech, Inc. and Washington Research Foundation. [532760] [CJF] [Entered: 06/29/2018 11:14 AM] (0) |
| Jun 26, 2018 | 18 | BRIEF FILED for Appellants Genentech, Inc. and Washington Research Foundation [17]. Number of Pages: 44. Service: 06/26/2018 by email. The paper copies of the brief should be received by the court on or before 07/05/2018. Appellees' brief is due 08/06/2018. [532217] [CFT] [Entered: 06/27/2018 10:24 AM] (92) |
| Jun 26, 2018 | 17 | TENDERED from Appellants Genentech, Inc. and Washington Research Foundation. Title: OPENING BRIEF. Service: 06/26/2018 by email. [532140] [18-1612] [David Gindler] [Entered: 06/26/2018 11:35 PM] (92) |
| May 1, 2018 | 16 | ORDER granting motion to extend time to file brief [12] filed by Appellants Genentech, Inc. and Washington Research Foundation. Appellants opening brief due 06/26/2018. Service: 05/01/2018 by clerk. [518143] [NL] [Entered: 05/01/2018 02:32 PM] (2) |
| Apr 20, 2018 | 15 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Appellants' motion [12] and reply [14] did not include certificates of compliance. CORRECTION: Pursuant to FRAP 32(g)(1), motions, responses to motions, and replies to responses must contain a certificate of compliance with the word count. Please ensure future motions and replies include the certificate of compliance. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [515780] [MJL] [Entered: 04/20/2018 04:21 PM] (0) |
| Apr 20, 2018 | 14 | REPLY of Appellants Genentech, Inc. and Washington Research Foundation to response filed by Appellees, Doc. No [13]. Service: 04/20/2018 by email. [515733] [18-1612] [Joshua Gordon] [Entered: 04/20/2018 03:17 PM] (5) |
| Apr 20, 2018 | 13 | RESPONSE of Appellees Sanofi and Sanofi-Aventis U.S., LLC to the motion to extend time to file brief [12] filed by Appellants Genentech, Inc. and Washington Research Foundation. Service: 04/20/2018 by email. [515589] [18-1612] [Lisa Ferri] [Entered: 04/20/2018 11:22 AM] (6) |
| Apr 12, 2018 | 12 | MOTION of Appellants Genentech, Inc. and Washington Research Foundation to extend the time to 06/26/2018 to file the Opening Brief.. Any response is due within 10 days of service. [Consent: opposed]. Service: 04/12/2018 by email. [513073] [18-1612] [Joshua Gordon] [Entered: 04/12/2018 11:26 PM] (14) |
| Apr 10, 2018 | 11 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [512165] [JB] [Entered: 04/10/2018 03:40 PM] (0) |
| Mar 12, 2018 | 10 | Entry of appearance for Josh B. Gordon as of counsel for Appellants Genentech, Inc. and Washington Research Foundation. Service: 03/12/2018 by email. [504309] [Joshua Gordon] [Entered: 03/12/2018 04:03 PM] (2) |
| Mar 12, 2018 | 9 | Docketing Statement for the Appellants Genentech, Inc. and Washington Research Foundation. Service: 03/12/2018 by email. [504303] [David Gindler] [Entered: 03/12/2018 04:00 PM] (4) |
| Mar 12, 2018 | 8 | Certificate of Interest for the Appellants Genentech, Inc. and Washington Research Foundation. Service: 03/12/2018 by email. [504300] [David Gindler] [Entered: 03/12/2018 03:59 PM] (4) |
| Mar 12, 2018 | 7 | Entry of appearance for David I. Gindler as principal counsel for Appellants Genentech, Inc. and Washington Research Foundation. Service: 03/12/2018 by email. [504296] [David Gindler] [Entered: 03/12/2018 03:57 PM] (2) |
| Mar 12, 2018 | 6 | Docketing Statement for the Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 03/12/2018 by email. [504249] [Lisa Ferri] [Entered: 03/12/2018 02:58 PM] (3) |
| Mar 12, 2018 | 5 | Certificate of Interest for the Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 03/12/2018 by email. [504247] [Lisa Ferri] [Entered: 03/12/2018 02:56 PM] (2) |
| Mar 12, 2018 | 4 | Entry of appearance for Manuel Jose Velez as of counsel for Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 03/12/2018 by email. [504243] [Manuel Velez] [Entered: 03/12/2018 02:53 PM] (2) |
| Mar 12, 2018 | 3 | Entry of appearance for Richard J. McCormick as of counsel for Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 03/12/2018 by email. [504242] [Richard McCormick] [Entered: 03/12/2018 02:49 PM] (2) |
| Mar 12, 2018 | 2 | Entry of appearance for Lisa M. Ferri as principal counsel for Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 03/12/2018 by email. [504158] [Lisa Ferri] [Entered: 03/12/2018 12:29 PM] (2) |
| Feb 26, 2018 | 1 | Appeal docketed. Received: 02/23/2018. [500981]Entry of Appearance due 03/12/2018. Certificate of Interest is due on 03/12/2018. Docketing Statement due 03/12/2018. Appellant/Petitioner's brief is due 04/27/2018. [JB] [Entered: 02/26/2018 11:34 AM] (34) |
